联合应用拮抗神经内分泌激素药物对心肌梗死后心室重构影响的临床研究
出处
《临床医药实践》
2005年第11期830-831,共2页
Proceeding of Clinical Medicine
二级参考文献11
-
1[1]Packer M, Cohn. JN. Consensus recommendations for the management of chronic heart failure. AmJ Cardiol, 1999, 83: 1A-5A.
-
2[2]ACC/AHA task force on practice guidelines. Guidelines for the evaluation and management of heart failure. Circulation, 1995, 92:2764-2784.
-
3[3]American Heart Association. Team management of patients with heart failure Dallas, TX 75231-4596: American Heart Association,2000 Jul. e-mail: pubauth@ heart. org.
-
4Pfeffer JM, Fischer TA, Pfeffer MA. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu Rev Physiol, 1995,57 ( 3 ) :808-826.
-
5Nomoto T, Nishina T, Miwa S,et al. Angiotensin-converting enzyme inhibitor helps prevent late remodeling after left ventricular aneurysm repair in rats. Circulation,2002,106 ( 12 Suppl 1 ) : 1115-1119.
-
6Patten RD,Aronovitz MJ,Einstein M,et al. Effects of angiotensin Ⅱ receptor blockade versus angiotensin-converting enzyme inhibition on ventricular remodeling following myocardial infarction in the mouse.Clin Sci ( Lond ) ,2003,04 ( 2 ) : 1009-1018.
-
7Mankad S,d Amato TA, Reichek N, et al. Combined angiotensin Ⅱ receptor antagonism and angiotensin-converting enzyme inhibition further attenuates postinfarction left ventricular remodeling. Circulation ,2001,103 ( 23 ) :2845-2850.
-
8Cavasin MA,Yang XP,Liu YH,et al. Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure. J Cardiovasc Pharmacol,2000,36 (4) :472-480.
-
9Richer C,Gervais M,Fones P,et al. Combined selective angiotensin Ⅱ AT1 -receptor blockade and angiotensin I-converting enzyme inhibition on coronary flow reserve in postischemic heart failure in rats.J Cardiovasc Pharmacol, 1999,34 ( 6 ) : 772-781.
-
10Nakamura Y, Yoshiyama M, Omura T, et al. Beneficial effects of combination of ACE inhibitor and angiotensin Ⅱ type 1 receptor blocker on cardiac remodeling in rat myocardial infarction. Cardiovasc Res,2003,57( 1 ) :48-54.
共引文献37
-
1任亚丽,虞珏,赵喜,孟国梁,徐济良.苯那普利及厄贝沙坦对心衰大鼠心脏指数及血流动力学的影响[J].南通大学学报（医学版）,2008,28(1):25-27. 被引量：3
-
2孙忠实,朱珠.心力衰竭药物治疗的抉择[J].中国药物应用与监测,2004,1(1):7-11.
-
3施志雄,刘伶.美托洛尔对充血性心力衰竭患者心室重塑和心功能的影响[J].广西医学,2004,26(7):947-948. 被引量：3
-
4王文丰,杨庭树.心肌梗死后拮抗神经内分泌治疗以逆转心室重构[J].中华老年心脑血管病杂志,2004,6(6):419-420. 被引量：3
-
5王文丰,杨庭树,冯斌,韩宝石.心肌梗死合并糖尿病的患者心室重构和血浆内分泌激素水平的临床研究[J].中华老年心脑血管病杂志,2005,7(1):20-23. 被引量：3
-
6王文丰,杨庭树,冯斌.拮抗神经内分泌激素药物治疗对心梗后心室重构及血浆内分泌激素影响的临床研究[J].中国实用内科杂志,2005,25(5):422-424. 被引量：2
-
7殷国田,谷高玲,赵国安,丁明伟.依那普利联合美托洛尔长疗程治疗对扩张型心肌病心功能的影响[J].中国煤炭工业医学杂志,2005,8(8):813-814.
-
8曲静伟,董文雅,洪中立.地高辛的血清浓度监测和剂量探讨[J].现代实用医学,2005,17(9):560-560. 被引量：5
-
9栾霞,盖淑香,李海英,董玲.螺内酯联合卡托普利治疗心肌梗死合并糖尿病患者的临床研究[J].实用糖尿病杂志,2005,1(5):43-44. 被引量：1
-
10王晓霞,黄伟,刘金萍,姚海文,朱继英.依那普利联合伊贝沙坦对慢性心力衰竭左室重构的作用观察[J].海南医学,2005,16(12):47-48. 被引量：1
-
1韩咏霞.糖尿病患者慎用激素药物[J].健康文摘,2009(5):40-40.
-
2敖文,碌越,朱首领.噻唑烷二酮类药物对糖尿病患者哮喘发作风险的队列研究[J].重庆医学,2015,44(21):2923-2925.
-
3刘占祥,韦安猛.痰热清注射液治疗慢性阻塞性肺疾病急性加重期100例[J].中原医刊,2007,34(24):27-28. 被引量：1
-
4长期用激素应防感染[J].中国农村医学杂志,2011,9(3):52-52.
-
5翟玉峰.38例老年患者继发真菌感染的临床分析[J].中国煤炭工业医学杂志,2003,6(5):423-423.
-
6尚军洁.拮抗神经内分泌激素药物对心肌梗死合并糖尿病患者心室重构和血浆内分泌激素水平的影响研究[J].中国医药科学,2015,5(21):81-83. 被引量：5
-
7靳艳芳.参麦注射液治疗慢性心力衰竭50例[J].河南职工医学院学报,2012,24(1):40-41.
-
8朱科金.重度溃疡性结肠炎临床特点及治疗转归研究[J].家庭心理医生,2015,11(2):63-63.
-
9胡友勇,李隆贵,赵国喜,耿召华.重组人生长激素治疗充血性心力衰竭[J].临床心血管病杂志,2001,17(10):442-444. 被引量：4
-
10赵颖军,付强,李占全.舒张性心力衰竭的诊断进展[J].中国医师进修杂志,2011,34(7):64-67. 被引量：3
